The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology
Oncolytics Biotech Inc. - Common Shares (ONCY)
Last oncolytics biotech inc. - common shares earnings: 11/12 04:00 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.oncolyticsbiotech.com
Company Research
Source: GlobeNewswire
VANCOUVER, British Columbia, March 19, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary — Big money is moving back into biotech. Institutional investors have been writing some of the largest checks in years, with major financing rounds already closing in the first months of 2026[1], a sign that capital is rotating toward clinical-stage companies with validated science. That capital is not spreading evenly: it is concentrating on precision medicine, where the global oncology precision medicine market is projected to reach $303 billion by 2035[2], growing at approximately 9% annually as targeted cancer treatments move from promising idea to standard care. The five companies in this report, Oncolytics Biotech (NASDAQ: ONCY), OS Therapies (NYSE-A: OSTX), Sensei Biotherapeutics (NASDAQ: SNSE), Atossa Therapeutics (NASDAQ: ATOS), and Tango Therapeutics (NASDAQ: TNGX), sit inside that window. Institutions are positioning for what analysts at Goldman Sachs are calling a potentia
Show less
Read more
Impact Snapshot
Event Time:
ONCY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ONCY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ONCY alerts
High impacting Oncolytics Biotech Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
ONCY
News
- Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Oncolytics Biotech® to Present New Mechanistic and Translational Data Supporting Pelareorep as an Immune-Priming Backbone at AACR 2026GlobeNewswire
- Oncolytics Biotech® Launches Randomized Colorectal Cancer Study [Yahoo! Finance]Yahoo! Finance
- Oncolytics Biotech® Launches Randomized Colorectal Cancer StudyGlobeNewswire
- Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026 [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
ONCY
Earnings
- 11/12/25 - Miss
ONCY
Sec Filings
- 3/20/26 - Form 8-K
- 3/19/26 - Form 8-K
- 3/13/26 - Form 4
- ONCY's page on the SEC website